CCM
MRVI icon

Cinctive Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Cinctive Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$1.28M – 482
2022
Q3 		$1.28M Buy
+50,000
New +$1.25M 0.05% 327

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Cinctive Capital Management's MRVI Position: Q4 2021 in Review

Cinctive Capital Management sold out of Maravai LifeSciences (MRVI) in Q4 2021, closing a stake of 84,058 shares — an estimated $4.13M sold.

Cinctive Capital Management first reported a position in MRVI in Q4 2020 and held it in 4 quarters. The position peaked at $4.13M in Q3 2021. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

  • Cinctive Capital Management reported no remaining Maravai LifeSciences position as of Q4 2021 after selling out during the quarter.
  • Cinctive Capital Management sold 84,058 Maravai LifeSciences shares in Q4 2021, an estimated $4.13M.
  • Cinctive Capital Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 4 quarters.
  • Cinctive Capital Management's Maravai LifeSciences position peaked at $4.13M in Q3 2021.
  • 229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on Cinctive Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.